Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - a chemiluminescent microparticle(cmia)assay for the qualitative detection of hepatitis b surface antigen in human clinical specimens. the architect hbsag qualitative ii assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected up to 24 hours post-mortem (non-heart-beating).

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - a chemiluminescent microparticle(cmia) assay for the confirmation of the presence of hbsag in clinical specimens. the architect hbsag qualitative ii confirmatory assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected up to 24 hours post-mortem.

Australia - English - Department of Health (Therapeutic Goods Administration)

roche diagnostics australia pty limited - 60812 - hepatitis b virus surface antigen neutralization ivd, kit, chemiluminescent immunoassay - the elecsys hbsag confirmatory test is based on the principle of specific antibody neutralization. polyclonal hbsag-specific antibodies bind to the immunodominant epitopes of the hepatitis b surface antigen and thereby block the binding sites for the antibodies used in the assay. immunoassay for in vitro confirmation of the presence of hepatitis b surface antigen in human serum and plasma samples repeatedly reactive when tested with the elecsys hbsag ii assay. this electrochemiluminescence (eclia) assay is intended for use on elecsys and cobas immunoassay analysers.

Australia - English - Department of Health (Therapeutic Goods Administration)

roche diagnostics australia pty limited - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - an electrochemiluminescence immunoassay "eclia" intended for use on the cobas e immunoassay analyzers. immunoassay for the in vitro qualitative determination of hepatitis b surface antigen (hbsag) in human serum and plasma, for diagnostic use, screening of blood donations.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - liaison? xl murex hbsag quant assay uses chemiluminescence immunoassay (clia) technology for the quantitative determination of hepatitis b surface antigen (hbsag) in human serum or plasma samples. for the quantitative determination of hepatitis b surface antigen (hbsag) in human serum and plasma samples, including specimens collected up to 24 hours post-mortem (non-heart beating).

Australia - English - Department of Health (Therapeutic Goods Administration)

ortho-clinical diagnostics australia pty ltd - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - for in vitro detection of hepatitis b surface antigen (hbsag) in clinical specimens for in vitro detection of hepatitis b surface antigen (hbsag) in clinical specimens

Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - paramagnetic particle, chemiluminescent immunoassay for qualitative detection of surface antigen hepatitis b virus hbs ag the access hbs ag assay is a paramagnetic particle, chemiluminescent immunoassay for the qualitative detection of the surface antigen of the hepatitis b virus (hbs ag) in human serum and plasma using the access immunoassay systems.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - the advia centaur hbsag confirmatory assay uses the principle of specific antibody neutralization to confirm the presence of hbsag in a sample that is repeatedly reactive for hbsag. an in vitro diagnostic immunoassay for the qualitative confirmation of the presence of hepatitis b surface antigen (hbsag) in clinical specimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - the advia centaur hbsagii assay is a magnetic particle chemiluminometric immunoassay used to measure the amount of hepatitis b surface antigen in human serum and plasma. an in vitro diagnostic immunoassay for the qualitative detection of hepatitis b surface antigen (hbsag) in clinical specimens. the assay may be used in conjunction with other serological and clinical information to diagnose individuals with acute or chronic hepatitis b infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 60812 - hepatitis b virus surface antigen neutralization ivd, kit, chemiluminescent immunoassay - the hbsag confirmatory test is an in vitro neutralization assay for confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma samples found repeatedly reactive for hbsag by liaison? xl murex hbsag quant or liaison? hbsag. ivd neutralization assay for confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma samples found repeatedly reactive for hbsag by liaison? xl murex hbsag quant or liaison? hbsag.